What is the appropriate acute management for a patient who ingested chlormequat chloride within the first hour, with a protected airway?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Management of Chlormequat Chloride Poisoning

For chlormequat chloride ingestion within the first hour with a protected airway, immediately administer high-dose atropine (2 mg IV for adults, 0.02 mg/kg for children) and repeat every 5-10 minutes until full atropinization is achieved, as chlormequat produces a cholinergic crisis identical to organophosphate poisoning but through direct receptor stimulation rather than cholinesterase inhibition. 1, 2

Critical Understanding of Chlormequat Toxicity

  • Chlormequat causes cholinergic crisis through direct nicotinic and muscarinic receptor stimulation, NOT through cholinesterase inhibition, distinguishing it from organophosphates but producing identical clinical symptoms. 1, 2
  • Death can occur within one hour of ingestion, making this an extreme medical emergency requiring immediate aggressive intervention. 2
  • The clinical presentation mimics nerve agent or organophosphate poisoning with salivation, diaphoresis, bradycardia, visual disturbances, seizures, pulmonary edema, and progression to ventricular fibrillation or asystole. 1

Immediate Pharmacologic Management

Atropine Administration (First-Line Therapy)

  • Administer atropine 2 mg IV immediately for adults (0.02 mg/kg for children) and repeat every 5-10 minutes until signs of full muscarinic antagonism appear. 3
  • Cumulative doses of 10-20 mg in the first 2-3 hours are typically required for adequate control of cholinergic symptoms, with total daily doses potentially reaching 50 mg. 3
  • Continue atropine until secretions are controlled, heart rate normalizes, and bronchospasm resolves—these are your clinical endpoints, not pupil size. 3
  • Atropine blocks muscarinic receptor overstimulation, controlling bronchoconstriction, excessive secretions, bradycardia, nausea, vomiting, and abdominal cramps. 3

Benzodiazepines for Seizure Control

  • Administer midazolam 0.05-0.1 mg/kg IV or diazepam 0.2 mg/kg IV in fractionated doses to control seizures, reduce anxiety, and facilitate mechanical ventilation if needed. 3
  • Benzodiazepines are essential adjuncts because chlormequat can cause CNS toxicity including seizures and severe agitation. 3, 1

Critical Difference: Oximes Are NOT Indicated

  • Do NOT administer pralidoxime or other oximes because chlormequat acts through direct receptor stimulation, not cholinesterase inhibition—oximes will be ineffective. 3, 1, 2
  • This distinguishes chlormequat management from organophosphate poisoning, where oximes are cornerstone therapy. 3

Airway and Respiratory Management

  • Maintain 100% oxygen and prepare for immediate intubation if respiratory distress develops, as pulmonary edema and bronchospasm are life-threatening complications. 3, 1
  • Regularly suction airways to clear excessive secretions that can cause airway obstruction and impair ventilation. 3
  • Use rapid sequence intubation with Sellick maneuver if intubation becomes necessary, treating the patient as having a full stomach due to vomiting and gastrointestinal symptoms. 3
  • Consider benzodiazepines as the primary sedation agents before intubation in this setting. 3

Cardiovascular Monitoring and Support

  • Continuous cardiac monitoring is mandatory because chlormequat causes bradycardia progressing to ventricular fibrillation and asystole. 1
  • Aggressive fluid resuscitation with crystalloids should be initiated for hypotension, as cholinergic crisis causes significant fluid shifts. 3
  • If severe cardiovascular collapse occurs despite atropine and fluids, use dopamine or epinephrine rather than norepinephrine, as their tachycardic effects counteract cholinergic bradycardia. 3

Gastrointestinal Decontamination (Within First Hour)

  • Gastric lavage may be considered within the first hour given the rapid lethality, though the airway must be protected first. 4
  • Do NOT induce vomiting, as this is contraindicated in toxic ingestions with risk of rapid deterioration. 3
  • Activated charcoal is unlikely to be beneficial for chlormequat and should not delay definitive antidotal therapy. 3

Expert Consultation

  • Immediately contact your regional poison control center (1-800-222-1222 in the US) for expert toxicology guidance, as chlormequat poisoning is rare and mortality is extremely high. 3, 5

Critical Pitfalls to Avoid

  • Do not wait for cholinesterase levels—they will be normal in chlormequat poisoning, and waiting wastes critical time. 1, 2
  • Do not underdose atropine—the required doses are far higher than typical medical uses, and inadequate atropinization is a common fatal error. 3
  • Do not assume stability after initial improvement—patients can deteriorate rapidly with ventricular arrhythmias and sudden death. 1, 2
  • Do not discharge early—observe for at least 24-48 hours given the risk of delayed cardiac complications and death within hours of ingestion. 2

Disposition

  • All chlormequat ingestions require ICU admission with continuous cardiac monitoring, given the documented risk of death within one hour and progression to fatal arrhythmias. 1, 2
  • Prolonged ventilatory support may be necessary for several days if pulmonary edema or respiratory failure develops. 3

References

Research

Sudden death following accidental ingestion of chlormequat.

Journal of analytical toxicology, 1990

Research

Chlormequat poisoning is not without risk: Examination of seven fatal cases.

Journal of forensic and legal medicine, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diquat Dibromide Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.